Psychemedics Corporation (PMDI)
OTCMKTS
· Delayed Price · Currency is USD
1.950
0.00 (0.00%)
At close: Dec 1, 2025
Psychemedics Employees
Psychemedics had 101 employees as of December 31, 2024. The number of employees decreased by 15 or -12.93% compared to the previous year.
Employees
101
Change (1Y)
-15
Growth (1Y)
-12.93%
Revenue / Employee
$194,901
Profits / Employee
-$18,426
Market Cap
11.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Psychemedics News
- 6 months ago - Psychemedics Releases 2025 Workforce Insights Report - GlobeNewsWire
- 7 months ago - Psychemedics Named “Most Innovative Drug Testing Company of the Year” - GlobeNewsWire
- 1 year ago - Psychemedics Corporation Announces Reverse and Forward Stock Split - GlobeNewsWire
- 1 year ago - Psychemedics Corporation Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing - GlobeNewsWire
- 1 year ago - Psychemedics Corporation Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Psychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common Stock - GlobeNewsWire
- 1 year ago - Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing - GlobeNewsWire